Investigators at Duke have turned to a new gene-editing tool to come up with a new approach to Duchenne muscular dystrophy that theoretically could apply to a majority of the boys afflicted with the fatal rare disease.
Over the last few years, testing psychedelic drugs against depression and other diseases of the brain has once again grown fashionable in some drug research groups. But now a team from Louisiana State University says that they have preclinical evidence to suggest that one of those drugs in the neurosciences spotlight could work against allergic asthma. Read more >>
GLP-1 treatments have become an important new class of diabetes drugs, offering a new way to control blood sugar among patients. Now a group of researchers at Cornell says it engineered a human probiotic that also had a similar effect in controlling blood glucose levels in rat models for the disease. And a biotech has already snagged the license on this work as they set the stage to try it in humans. Read more >>
POPULAR COMMENT THREADS
Researchers in the lab of MIT's Robert Langer have created a hydrogel that's designed to be much better than current technologies in getting drugs into patients and straight to where they are targeted.
Scientists at some of the most prestigious research institutions in the U.K. and Sweden say they've found a molecule that could disarm the toxic clusters of amyloid beta that are believed to trigger Alzheimer's, offering a new approach to treating the disease.
Investigators at the University of California-San Diego say they've identified a crucial link between obesity and diabetes, and now they're zeroing in on a new drug that can break it.
Researchers at The University of Texas MD Anderson Cancer Center say they've devised a new strategy for attacking breast cancer tumors before they metastasize.
While Sanofi has been working long and hard on a promising late-stage dengue vaccine, investigators in the field believe that there are some real limitations to its effectiveness. Now a team led by Duke-NUS Graduate Medical School Singapore has discovered an antibody which they say has demonstrated a powerful effect against the dengue virus, pointing to a possible new therapy that can fight it.
Researchers at the Wistar Institute say that they have zeroed in on a potential new therapeutic target for a subset of the most aggressive cases of ovarian cancer. And they're heralding the discovery as a big step toward the first effective therapy for the lethal disease.
From Our Sister Sites
Israeli-American biotech Chiasma has raised $70 million in Series E cash, moving on from an aborted collaboration with Roche and rolling toward FDA approval with a treatment for the hormone disorder acromegaly.
Amid growing backlash over the use of laparoscopic power morcellator devices in minimally invasive gynecological procedures, the U.S.'s largest health insurer is tightening its reins on coverage for hysterectomies.